We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
Seegene

Seegene

  Gold Seegene, Inc. is a developer of multiplex molecular technologies and multiplex clinical molecular diagnostics for inf... read more Featured Products: More products

Download Mobile App





2021 AACC to Showcase Cutting-Edge Science and Technology Shaping Future of Laboratory Medicine

By LabMedica International staff writers
Posted on 31 Aug 2021
Print article
Illustration
Illustration
The 2021 American Association for Clinical Chemistry (AACC; Washington, DC, USA) Annual Scientific Meeting & Clinical Lab Expo will be a live event that will explore the cutting-edge science and technology shaping the future of laboratory medicine.

Every year, the global laboratory medicine community comes together as one at the AACC Annual Scientific Meeting & Clinical Lab Expo to collaborate and create system-wide changes that improve patient outcomes and quality of life for all. AACC's annual meeting is the world's largest lab medicine conference with nearly 20,000 participants from more than 100 countries. Each year AACC hosts the conference in a new city that provides an exciting backdrop for the premier meeting in the field of laboratory medicine. AACC has moved the location of its 2021 annual meeting from Anaheim, California to Atlanta, Georgia and also changed the meeting dates to one week later: September 26-30, 2021.

The AACC Annual Scientific Meeting includes hundreds of educational sessions on a wide variety of timely laboratory medicine topics. AACC's annual meeting offers five days packed with opportunities to learn about exciting science. Plenary sessions will feature expert presentations on using tumor DNA in the blood to diagnose and monitor cancer, reducing the risk of heart disease, transparency in healthcare delivery, the latest advances that could lead to a cure for HIV, and new tests and treatment for infection.

Attendees will not only benefit from a stunning lineup of expert speakers and scientific sessions, but can also see a vast array of emerging technologies and products at the world's largest exhibition for in vitro diagnostics. The Clinical Lab Expo is the exhibit tradeshow of the AACC Annual Scientific Meeting and will host exhibitors in all areas of clinical laboratory science. At this year’s AACC Clinical Lab Expo, more than 700 exhibitors will display the latest diagnostic technology, including but not limited to mobile health, molecular diagnostics, mass spectrometry, point-of-care, and automation.

The AACC Annual Scientific Meeting will hold Lecture Series Presentations where attendees will learn about the latest technologies and services in convenient, 20-minute presentations covering topics such as “The Challenge and Promise of Launching COVID-19 Testing in Small and Non-Traditional Labs.” Additionally, Industry Workshop presentations will be held on new diagnostic breakthroughs and critical lab medicine topics such as “Mitigating Pre-analytical Errors in Point-of-Care Blood Gas Testing With a Total Quality Assurance Program” and “COVID-19 Testing at the Point of Care: New Platform for High Sensitivity Antigen and Antibody Testing,” among others.

Related Links:
American Association for Clinical Chemistry

New
Gold Supplier
SARS-CoV-2 S-IgG Antibody Assay
Lumipulse G SARS-CoV-2 S-IgG
New
Silver Supplier
Lipid Profile Analyzer
Cholestech LDX
New
Single Channel Pipette
AHN pipet4u pro
New
Gold Supplier
SARS-COV-2 PLUS UK Real Time PCR kit
SARS-COV-2 PLUS UK REALTIME PCR KIT

Print article
AACC

Channels

Pathology

view channel
Image: The CellSearch Circulating Tumor Cell Kit is intended for the enumeration of circulating tumor cells of epithelial origin (CD45-, EpCAM+, and cytokeratins 8, 18+, and/or 19+ and PD-L1) in whole blood (Photo courtesy of CellSearch/Menarini Silicon Biosystems)

PD-L1 Expression in Circulating Tumor Cells Investigated for NSCLC

In non-small cell lung cancer (NSCLC), analysis of programmed cell death ligand 1 (PD-L1) expression in circulating tumor cells (CTCs) is a potential alternative to overcome the problems linked to the... Read more

Industry

view channel
Illustration

Global Digital Polymerase Chain Reaction (dPCR) Market Projected to Reach Close to USD 1.15 Billion by 2028

The global digital polymerase chain reaction (dPCR) market is projected to grow at a CAGR of more than 9% from over USD 0.50 billion in 2020 to nearly USD 1.15 billion by 2028, driven primarily by rising... Read more
Copyright © 2000-2021 Globetech Media. All rights reserved.